Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 6818
Recalled November 13, 2019 · FDA recall D-0306-2020 · Lupin Pharmaceuticals
Hazard
Presence of Foreign substance: identified as a dead ant. · FDA Class III
Units
a) 4074 bottles b) 30,300 bottles
Sold at
Product was distributed to major distributors/wholesalers throughout the United States.
Description
Presence of Foreign substance: identified as a dead ant.
Product
Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →